insulin detemir

Known as: Des-(B30)-insulin, Lys(B29)-tetradecanoyl, Detemir, B29 tetradecanoyl Lys B30 des Ala insulin 
A recombinant long-acting insulin and HYPOGLYCEMIC AGENT in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
0204019922018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
BACKGROUND Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
This 52-week multinational, randomised, open-label, parallel-group, non-inferiority trial compared clinical outcomes following… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Adding insulin to oral therapy in type 2 diabetes mellitus is customary when glycemic control is suboptimal, though… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE To assess efficacy and tolerability of insulin detemir or NPH insulin added to oral therapy for type 2 diabetes in a… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Many patients with poorly controlled type 2 diabetes mellitus (DM) receive, as initial insulin treatment, the addition… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The aim of this randomized double-blind study was to compare the within-subject variability of the glucose-lowering effect of a… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The aim of the trial was to compare the efficacy and tolerability of two types of basal-bolus therapy, using either the soluble… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Purpose. Insulin detemir has been found in clinical trials to be absorbed with very low variability. A series of experiments were… (More)
  • table I
  • table II
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
This trial compared the efficacy and safety of basal-bolus therapy using either the soluble basal insulin analogue insulin… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
In recent years, analogs of human insulin have been engineered with the aim of improving therapy for people with diabetes. To… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?